APA

Mans D. R., Di Leone L., Ferrary Caldas A. P., Maino M., Almeida L., Cancela A. I., Grivicich I., Brondani da Rocha A. & Schwartsmann G. (20010329). Cellular and clinical pharmacokinetic/pharmacodynamic basis for lack of efficacy of 21-day continuous topotecan in patients with untreated advanced adenocarcinoma of the pancreas. : Tumori.

Chicago

Mans D R, Di Leone L, Ferrary Caldas A P, Maino M, Almeida L, Cancela A I, Grivicich I, Brondani da Rocha A and Schwartsmann G. 20010329. Cellular and clinical pharmacokinetic/pharmacodynamic basis for lack of efficacy of 21-day continuous topotecan in patients with untreated advanced adenocarcinoma of the pancreas. : Tumori.

Harvard

Mans D. R., Di Leone L., Ferrary Caldas A. P., Maino M., Almeida L., Cancela A. I., Grivicich I., Brondani da Rocha A. and Schwartsmann G. (20010329). Cellular and clinical pharmacokinetic/pharmacodynamic basis for lack of efficacy of 21-day continuous topotecan in patients with untreated advanced adenocarcinoma of the pancreas. : Tumori.

MLA

Mans D R, Di Leone L, Ferrary Caldas A P, Maino M, Almeida L, Cancela A I, Grivicich I, Brondani da Rocha A and Schwartsmann G. Cellular and clinical pharmacokinetic/pharmacodynamic basis for lack of efficacy of 21-day continuous topotecan in patients with untreated advanced adenocarcinoma of the pancreas. : Tumori. 20010329.